A detailed history of Palisade Capital Management LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Palisade Capital Management LLC holds 44,243 shares of BDX stock, worth $9.97 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
44,243
Previous 45,243 2.21%
Holding current value
$9.97 Million
Previous $10.6 Million 0.88%
% of portfolio
0.33%
Previous 0.34%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$221.47 - $242.41 $221,470 - $242,410
-1,000 Reduced 2.21%
44,243 $10.7 Million
Q2 2024

Aug 14, 2024

SELL
$225.07 - $246.17 $2.1 Million - $2.3 Million
-9,330 Reduced 17.1%
45,243 $10.6 Million
Q1 2024

May 15, 2024

SELL
$233.45 - $247.73 $1.4 Million - $1.49 Million
-6,002 Reduced 9.91%
54,573 $13.5 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $448,919 - $516,555
-1,933 Reduced 3.09%
60,575 $14.8 Million
Q3 2023

Nov 14, 2023

BUY
$254.9 - $283.59 $395,095 - $439,564
1,550 Added 2.54%
62,508 $16.2 Million
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $491,083 - $546,559
2,060 Added 3.5%
60,958 $16.1 Million
Q1 2023

May 08, 2023

BUY
$229.71 - $259.35 $1.93 Million - $2.17 Million
8,382 Added 16.59%
58,898 $14.6 Million
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $2.36 Million - $2.78 Million
10,830 Added 27.29%
50,516 $12.9 Million
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $349,810 - $1.81 Million
6,855 Added 20.88%
39,686 $8.84 Million
Q2 2022

Aug 10, 2022

BUY
$234.74 - $275.42 $851,636 - $999,223
3,628 Added 12.42%
32,831 $8.09 Million
Q1 2022

May 09, 2022

SELL
$243.64 - $270.48 $3.73 Million - $4.14 Million
-15,322 Reduced 34.41%
29,203 $7.77 Million
Q4 2021

Feb 10, 2022

BUY
$230.08 - $250.94 $11,504 - $12,547
50 Added 0.11%
44,525 $11.2 Million
Q3 2021

Nov 15, 2021

BUY
$232.72 - $256.47 $77,263 - $85,148
332 Added 0.75%
44,475 $10.9 Million
Q2 2021

Aug 12, 2021

BUY
$232.65 - $254.58 $76,076 - $83,247
327 Added 0.75%
44,143 $10.7 Million
Q1 2021

May 12, 2021

BUY
$232.09 - $256.88 $466,965 - $516,842
2,012 Added 4.81%
43,816 $10.7 Million
Q4 2020

Feb 11, 2021

BUY
$221.92 - $245.94 $61,028 - $67,633
275 Added 0.66%
41,804 $10.5 Million
Q3 2020

Nov 12, 2020

SELL
$215.77 - $276.76 $1.78 Million - $2.28 Million
-8,227 Reduced 16.53%
41,529 $9.66 Million
Q2 2020

Aug 06, 2020

SELL
$219.9 - $263.41 $1.21 Million - $1.44 Million
-5,485 Reduced 9.93%
49,756 $11.9 Million
Q1 2020

May 13, 2020

BUY
$195.69 - $279.01 $701,744 - $1 Million
3,586 Added 6.94%
55,241 $12.7 Million
Q4 2019

Feb 04, 2020

BUY
$236.45 - $266.82 $1.31 Million - $1.48 Million
5,546 Added 12.03%
51,655 $14 Million
Q3 2019

Nov 06, 2019

BUY
$230.58 - $256.08 $175,701 - $195,132
762 Added 1.68%
46,109 $11.7 Million
Q2 2019

Aug 06, 2019

SELL
$217.4 - $246.08 $2.18 Million - $2.47 Million
-10,046 Reduced 18.14%
45,347 $11.4 Million
Q1 2019

May 13, 2019

SELL
$206.05 - $248.17 $295,063 - $355,379
-1,432 Reduced 2.52%
55,393 $13.8 Million
Q4 2018

Feb 12, 2019

SELL
$204.73 - $257.93 $886,071 - $1.12 Million
-4,328 Reduced 7.08%
56,825 $12.8 Million
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $100,220 - $110,080
430 Added 0.71%
61,153 $16 Million
Q2 2018

Aug 13, 2018

BUY
$208.1 - $233.85 $685,481 - $770,301
3,294 Added 5.74%
60,723 $14.5 Million
Q1 2018

May 09, 2018

BUY
$205.46 - $240.27 $655,828 - $766,941
3,192 Added 5.89%
57,429 $12.4 Million
Q4 2017

Feb 09, 2018

BUY
$189.0 - $222.64 $302,778 - $356,669
1,602 Added 3.04%
54,237 $11.6 Million
Q3 2017

Oct 31, 2017

BUY
$186.89 - $198.9 $9.84 Million - $10.5 Million
52,635
52,635 $10.3 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Palisade Capital Management LLC Portfolio

Follow Palisade Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Capital Management LLC with notifications on news.